Good Distribution Practice (GDP)

What Good Distribution Practice is

Good Distribution Practice (GDP) is the set of standards ensuring medicinal products are stored, transported, and handled under conditions that preserve their quality and integrity through the supply chain — from the manufacturer to the point they reach the patient. In the EU the reference is the Guidelines on GDP of medicinal products for human use (2013/C 343/01); equivalent expectations exist in other regions, and a separate set of GDP guidelines covers active substances.

GDP covers the physical disciplines — temperature control and cold chain, premises and equipment, transportation and routing, handling of returns, and controls against falsified medicines — and it requires the appointment of a Responsible Person (RP) accountable for the quality system and GDP compliance at a wholesale distributor. But its opening chapter is a quality system, and the chapters on documentation, personnel and training, complaints, deviations, self-inspection, and outsourced activities are pure quality-management work.

GDP applies to wholesale distributors, but also to manufacturers who distribute their own products and, in practice, to the brokers and logistics providers in between. A break anywhere in that chain — a temperature excursion in transit, a falsified product entering through a poorly-qualified supplier — can compromise a product that left the factory perfect.

Why GDP is its own inspection

A GDP authorisation (a Wholesale Distribution Authorisation in the EU) is inspected in its own right, separately from GMP, and a GDP non-compliance can suspend a distributor's authorisation — stopping product movement entirely. Wholesale distributors, and manufacturers who also distribute, must demonstrate a functioning quality system: current SOPs at every site, trained staff with defined responsibilities including the RP, deviations and complaints handled and trended, suppliers and customers qualified before trading, and a self-inspection programme that actually finds and closes issues.

The supply chain is also the front line against falsified medicines: GDP's supplier and customer qualification requirements, combined with the EU Falsified Medicines Directive's verification at dispensing, are how counterfeit and diverted product is kept out of the legitimate chain. A distributor who trades with an unqualified supplier has opened the door, and that qualification evidence is a quality-system record.

The recurring findings are quality-system findings — uncontrolled or out-of-date procedures, training gaps, deviations closed without investigation, supplier qualification missing or stale, self-inspections that are performed but never drive corrective action. The cold chain gets the headlines and the capital investment; the QMS records decide the inspection.

Where GDP requirements live

• EU GDP Guidelines 2013/C 343/01 — the primary EU reference: quality system, personnel, premises/equipment, documentation, operations, complaints/returns/falsified products, outsourced activities, self-inspection, transportation
• EU GDP for Active Substances (2015/C 95/01) — the parallel guidelines covering APIs in distribution
• EU Falsified Medicines Directive (2011/62/EU) — supply-chain integrity and verification, interlocking with GDP supplier/customer controls
• WHO GDP guidance (TRS series) — the global reference many non-EU jurisdictions model their GDP rules on
• EU GMP Chapter 1 — the pharmaceutical quality system, of which GDP's quality system is the distribution-facing extension
• PIC/S GDP guide (PE 011) — the PIC/S equivalent applied by participating authorities
• National GDP regulations — most jurisdictions have their own GDP rules and inspectorates; the EU guidelines are the most widely modelled

What a GDP inspection probes

A GDP inspection of a distribution site walks the quality system as much as the warehouse. Beyond checking temperature-mapping records and walking the storage areas, inspectors test the QMS behind the operation:

The quality system and RP. Is there a documented quality system with current SOPs at this site? Is the Responsible Person appointed, trained, and actually exercising oversight — with records of their decisions, approvals, and reviews? An RP who is named but not demonstrably active is a finding.

Deviations and complaints. How are temperature excursions, damaged-goods events, and customer complaints handled? Are they governed deviations with investigation and CAPA, or are they logged and forgotten? Inspectors follow specific excursions into the record.

Supplier and customer qualification. Is every supplier and customer qualified before trading — verified authorisation, bona fides checked — and re-qualified on a cadence? This is the falsified-medicines firewall, and gaps here are taken seriously.

Self-inspection. Is there a self-inspection programme, is it performed on schedule, and — critically — do its findings drive documented corrective action? A self-inspection programme that never finds anything, or finds things that are never fixed, is worse than none.

The temperature data lives in monitoring systems and the goods move on qualified vehicles; but the SOPs, the RP's oversight records, the deviations, the qualification files, and the self-inspection reports are quality-system records, and their completeness decides the inspection.

What strong GDP quality systems share

The cold chain is engineering; these are the quality-system controls that make a GDP operation defensible:

• Current, site-specific SOPs — controlled, one effective version, covering each GDP activity at each site
• An active Responsible Person — appointed, trained, with documented oversight, approvals, and decisions
• Trained personnel with defined roles — GDP training delivered and recorded, responsibilities clear
• Governed deviations and complaints — excursions, damage, and complaints investigated and trended, not just logged
• Supplier and customer qualification — verified before trading, re-qualified on cadence (the falsified-medicines firewall)
• Outsourced-activity agreements — written contracts with logistics and storage providers defining GDP responsibilities
• A working self-inspection programme — scheduled, performed, with findings driven to closure via CAPA
• Returns and falsified-product procedures — defined handling and quarantine, with records
• Temperature-excursion management — defined limits, impact assessment on product, documented decisions

How Complere supports GDP quality work

Complere governs the GDP quality-system layer — not the warehouse, not the vehicles, not the cold chain. Those are facility and logistics functions, and an eQMS claiming to monitor temperature or qualify a refrigerated truck would be overstepping. What Complere does govern is the set of records a GDP inspection actually reads.

Controlled SOPs across distribution sites — one effective version, full revision history, retirement of superseded procedures — so each site works to current instructions. Role-based training with completion evidence and competency sign-off, including the Responsible Person and site staff, answering “is everyone trained on the current GDP procedures.” Deviations and complaints — temperature excursions, damaged goods, customer complaints — captured, investigated, and trended, with the impact-on-product assessment recorded. Supplier and customer qualification records maintained as controlled evidence. And a self-inspection programme run in Audit Management, where findings are captured, classified, and driven to closure through linked CAPAs — closing the loop the inspection checks for.

Temperature mapping, vehicle qualification, and cold-chain monitoring stay with your specialised systems; Complere holds the governed records that prove the quality system around them works — the SOPs, the RP's oversight, the deviations, the qualification files, and the self-inspection trail an inspector asks to see first.

Terms related to Good Distribution Practice

GDP extends the quality system into the supply chain. Explore related terms to build a complete picture.

• Document Control — keeps distribution SOPs current and controlled
• Supplier Qualification — the supply-chain-integrity firewall
• Internal Audit — the self-inspection programme's mechanism
• Deviation — how excursions and complaints are governed
• Training Management — GDP training and competency evidence
• CAPA — where self-inspection and deviation findings drive action